Frankfurt
11.09.26 | 08:00
0,012 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:45 | Acarix AB: Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test | 143 | GlobeNewswire (Europe) | Aalborg University-led research, published in PLOS Digital Health, found the CADScor System's acoustic sensing platform identified heart failure with diagnostic accuracy comparable to a leading blood... ► Artikel lesen | |
| 13.08. | Acarix AB Q2 Sales Increase | 10 | RTTNews | ||
| 13.08. | Earnings Call: Acarix meldet starkes Wachstum für Q2 2026, doch die Aktie gibt nach | 10 | Investing.com Deutsch | ||
| ACARIX Aktie jetzt für 0€ handeln | |||||
| 13.08. | Acarix Q2 2026 slides: US revenue surges 212%, losses narrow | 5 | Investing.com | ||
| 13.08. | Acarix Q2 2026 slides: revenue doubles as US growth accelerates | 1 | Investing.com | ||
| 13.08. | Acarix AB: Acarix Publishes Second Quarter and First Half 2026 Results | 165 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the second quarter and first half 2026. The report highlights continued commercial... ► Artikel lesen | |
| 17.06. | Acarix AB: Announcement from the annual general meeting in Acarix AB | 283 | GlobeNewswire (Europe) | The annual general meeting 2026 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 17 June 2026 and the following resolutions were passed by the meeting.
Adoption of the income statement... ► Artikel lesen | |
| 18.05. | Earnings Call: Acarix verzeichnet starkes US-Wachstum im ersten Quartal 2026 | 2 | Investing.com Deutsch | ||
| 18.05. | Acarix AB: Acarix Publishes Interim Report, January - March 2026 | 301 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the first quarter of 2026. The report highlights meaningful progress across the... ► Artikel lesen | |
| 12.02. | Acarix AB: Acarix Publishes Year-End Report 2025 | 294 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end financial results. "Last year was a year of meaningful commercial and operational... ► Artikel lesen | |
| 11.02. | Acarix AB: Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System | 453 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics for coronary artery disease, today announced that it has entered into a strategic... ► Artikel lesen | |
| 04.02. | Acarix AB: Acarix Receives EU MDR Certification for the CADScorSystem | 396 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor System has successfully achieved certification under the European Union Medical... ► Artikel lesen | |
| 06.11.25 | Acarix AB: Acarix Publishes Interim Report, Third quarter 2025 | 286 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the third quarter of 2025. The report highlights international... ► Artikel lesen | |
| 27.10.25 | Acarix AB: Announcement from the general meeting in Acarix AB | 343 | GlobeNewswire (Europe) | The extraordinary general meeting 2025 (the "EGM") of Acarix AB ("Acarix" or the "Company") was held today on 27 October 2025 and the following resolutions were passed unanimously by the meeting.
Change... ► Artikel lesen | |
| 17.10.25 | Acarix AB: Acarix responds to G-BA decision on reimbursement in the German market | 386 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that G-BA reached a negative decision on the possibility for CADScor System to receive reimbursement... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 38,940 | +1,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,220 | +0,58 % | EQS-DD: Carl Zeiss Meditec AG: Justus Felix Wehmer, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
04.09.2026 / 17:25... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,370 | +0,65 % | ALARMSTUFE ROT bei Eckert&Ziegler: 3,18% Kurseinbruch erschüttert den Markt! | ||
| UNITEDHEALTH | 335,40 | +0,30 % | UnitedHealth Reshapes Florida WellMed Operations With TPG Deal | ||
| HIMS & HERS HEALTH | 23,380 | -1,10 % | ROUNDUP/Aktien New York Schluss: Chipwerte belasten Nasdaq | NEW YORK (dpa-AFX) - Technologieaktien haben am Montag in den USA wieder einmal geschwächelt. Standardwerte legten dagegen überwiegend moderat zu. Negative Vorgaben aus Asien, die am Mittwoch nachbörslich... ► Artikel lesen | |
| BICO GROUP | 1,838 | +0,55 % | BICO Group AB: Publication of BICO Group AB: Interim Report Q2 2026 | Improved profitability and AI advancements
"In the quarter we had a continued solid momentum with growth in our bench top instruments and consumables businesses, while still experiencing challenges... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| SPINEWAY | 0,121 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,050 | -8,73 % | Unidoc Health Corp: Unidoc Health has no material changes | ||
| VERU | 2,500 | 0,00 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| VIROMED MEDICAL | 5,500 | -0,90 % | EQS-DD: Viromed Medical AG: Heike Perbandt, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.09.2026 / 18:23... ► Artikel lesen | |
| CLARIANE | 3,986 | 0,00 % | Clariane announces the success of its 2032 €500 million senior notes offering and a new €700m syndicated RCF (5 years, same terms) - subject to final settlement of the notes | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO... ► Artikel lesen | |
| BONESUPPORT | 19,600 | -2,49 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q2 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2026.
"Strong growth and improved operating... ► Artikel lesen | |
| SENSEONICS | 7,550 | 0,00 % | Senseonics sees activist investor take a major stake |
ACARIX AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,012 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACARIX AB finden Sie auf Wallstreet Online.